MedAvail Holdings, Inc. |
42.88 |
ADC Therapeutics SA |
19.01 |
Fate Therapeutics |
13.27 |
Shattuck Labs, Inc. |
11.84 |
Annexon, Inc. |
10.34 |
Zymeworks Inc. |
9.19 |
IGM Biosciences, Inc. |
9.03 |
Atara Biotherapeutics |
8.93 |
Scholar Rock Holding Corporation |
8.88 |
Absci Corporation |
8.64 |
REGENXBIO |
8.46 |
Epizyme, Inc. |
8.33 |
Lava Therapeutics B.V. |
7.89 |
ALX Oncology Holdings Inc. |
7.35 |
Krystal Biotech, Inc. |
7.1 |
Immunome |
7.09 |
ImmunoGen |
6.57 |
Replimune Group, Inc. |
6.3 |
Neoleukin Therapeutics, Inc. |
6.2 |
Gritstone Oncology, Inc. |
5.99 |
Deciphera Pharmaceuticals, Inc. |
5.94 |
Stoke Therapeutics, Inc. |
5.88 |
Repare Therapeutics Inc. |
5.09 |
Amicus Therapeutics, Inc. |
5.02 |
Pliant Therapeutics, Inc. |
4.48 |
Allakos Inc. |
4.2 |
Achilles Therapeutics plc |
3.94 |
Entrada Therapeutics, Inc. |
3.85 |
RayzeBio, Inc. Common Stock |
3.1 |
IVERIC bio, Inc. |
3.05 |
Stereotaxis, Inc. |
1.84 |
TCR2 Therapeutics Inc. |
1.68 |
AlloVir, Inc. |
1.66 |
Zymergen Inc. |
1.49 |
Atreca, Inc. |
1.35 |
Invivyd, Inc. |
1.31 |
HOOKIPA Pharma Inc. |
1.3 |
Eidos Therapeutics, Inc. |
1.21 |
Science 37 Holdings, Inc. |
0.83 |
Invitae Corporation |
0.8 |
Alpha Teknova, Inc. |
0.39 |
Augmedix, Inc. |
0 |